News

Subjective memory complaints predict clinical impairment


 

AT CTAD

The risk of an observed impairment was significantly reduced by the use of antihypertensives (HR, 0.34) and a report of high cholesterol (HR, 0.75).

Dr. Abner acknowledged certain limitations of the study, including the fact that most clinical impairments are not yet confirmed by medical review. In addition, "relevant early to midlife socioeconomic status exposures were not measured, which may mitigate the effect observed for black race," she said. "Also, many of our black participants were recruited from Veterans Affairs sites, so their exposures may be qualitatively different in terms of their risk of head trauma and PTSD [posttraumatic stress disorder]. Overall, the sample was highly educated and healthy."

Screening of the full PREADVISE cohort is expected to be completed in early 2014.

The study is funded by the National Institute on Aging. Dr. Abner said she had no relevant financial conflicts to disclose.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

FDA okays flutemetamol for color-enhanced amyloid imaging
MDedge Psychiatry
Johnson & Johnson agrees to pay billions in drug misbranding settlement
MDedge Psychiatry
Don’t ignore headaches in teens with bipolar disorder
MDedge Psychiatry
Dementia, bizarre creatures, and a white knight to the rescue
MDedge Psychiatry
Treating Alzheimer's disease
MDedge Psychiatry
Small study: TBI leads to rapid deposition of brain amyloid
MDedge Psychiatry
Nerve growth factor gene therapy delivered safely in Alzheimer’s patients
MDedge Psychiatry
Memantine helped to delay driving impairment in early Alzheimer’s
MDedge Psychiatry
Good news: ‘fibrofog’ doesn’t portend Alzheimer’s
MDedge Psychiatry
Cholinesterase inhibitors most effective in mild Alzheimer’s
MDedge Psychiatry